I-Mab to Participate in Leerink Partners Global Healthcare Conference<blockquote>I-Mab将参加Leerink Partners全球医疗保健大会</blockquote>
ROCKVILLE, Md., Feb. 18, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a US-based, global biotech company, exclusively focused on the development of precision immune-oncology agents